Sorrento granted FDA clearance to start late-stage trial for COVID-19 therapy
March 31 2022 - 9:29AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Sorrento Therapeutics (NASDAQ:SRNE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sorrento Therapeutics (NASDAQ:SRNE)
Historical Stock Chart
From Apr 2023 to Apr 2024